[{"NetIncomeLoss_1_Q1_USD":-26376000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":381000.0,"AssetsCurrent_0_Q1_USD":196783000.0,"OperatingLeaseExpense_1_Q1_USD":109000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4072000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":852000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":372000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-316000.0,"CommonStockSharesIssued_0_Q1_shares":24631000.0,"ShareBasedCompensation_1_Q1_USD":5565000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1440000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":235000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":391000.0,"Assets_0_Q1_USD":200389000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-703000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":64000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ResearchAndDevelopmentExpense_1_Q1_USD":14741000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":1838000.0,"CommonStockValue_0_Q1_USD":25000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":403000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":65000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":852000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":6528000.0,"OtherAssetsNoncurrent_0_Q1_USD":633000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1328000.0,"Liabilities_0_Q1_USD":13652000.0,"OperatingLeaseLiability_0_Q1_USD":1603000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":11638000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":24524000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":194015000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":267000.0,"CommonStockSharesAuthorized_0_Q1_shares":50000000.0,"OperatingIncomeLoss_1_Q1_USD":-26379000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5565000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-19640000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":363000.0,"LiabilitiesCurrent_0_Q1_USD":12324000.0,"AccountsPayableCurrent_0_Q1_USD":5310000.0,"InterestExpense_1_Q1_USD":7000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":427000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":194015000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":852000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":189000.0,"AdditionalPaidInCapital_0_Q1_USD":351945000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":9000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1533000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":2768000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":null,"CommonStockSharesOutstanding_0_Q1_shares":24631000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-165233000.0,"InvestmentIncomeInterest_1_Q1_USD":10000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":200389000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1304000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5565000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-19104000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":1960000.0,"OperatingExpenses_1_Q1_USD":26379000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.08,"OtherLiabilitiesCurrent_0_Q1_USD":275000.0,"StockholdersEquity_0_Q1_USD":186737000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":316000.0,"TaxesPayableCurrent_0_Q1_USD":743000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":275000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":1640000.0,"Ticker":"BTAI","CIK":"1720893","name":"BIOXCEL THERAPEUTICS, INC.","OfficialName":"BioXcel Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"417746551.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]